In cell therapy, cost is a hot issue. The industry might need a cold solution.

by admin | Aug 29, 2025 | News & Opinions

by Michael Gibney – PharmaVoice – The first cell therapy approved by the FDA, Dendreon’s Provenge for prostate cancer, had a bumpy start on the market in 2010, as the autologous treatment was logistically difficult to manufacture and administer, and thus...

New activated cell therapy to treat osteoarthritis

by admin | Aug 28, 2025 | News & Opinions

By Sarah Nesbella – Colorado State University – Osteoarthritis (OA) affects over 550 million people worldwide, and there still aren’t effective treatments to stop the continued joint inflammation and cartilage destruction caused by OA. The lifetime...

UCLA scientists develop off-the-shelf immunotherapy for ovarian cancer

by admin | Aug 27, 2025 | News & Opinions

By Linda Wang – UCLA Newsroom – Ovarian cancer is the leading cause of death among women with gynecological cancers. The current medical playbook — surgery followed by chemotherapy — initially shows promise. Tumors shrink, sometimes disappearing entirely....

Japan MHLW approves Biostar’s angel stem cell therapy for autism

by admin | Aug 26, 2025 | News & Opinions

By Pharmaceutical Technology News – Biostar Stem Cell Technology Research Institute has received the Japanese Ministry of Health, Labour and Welfare (MHLW) approval for its angel stem cell therapy for autism spectrum disorder (ASD). Biostar is jointly operated...

Stem cell-derived dopamine neurons improve depression-like behaviors in mice

by admin | Aug 25, 2025 | News & Opinions

by Justin Jackson – Phys.org – MedicalXpress – The Institute of Neuroscience, Chinese Academy of Sciences, reports that human stem cell-derived A10-like midbrain dopaminergic neurons integrate into mouse mesocorticolimbic circuits and suppress...